Title
Correction: ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors (Clinical Cancer Research (2018) 24 (2517–29) DOI: 10.1158/1078-0432.CCR-17-2904)
Date Issued
15 February 2019
Access level
open access
Resource Type
corrigendum
Author(s)
Guerrero-Zotano A.L.
Stricker T.P.
Formisano L.
Hutchinson K.E.
Stover D.G.
Lee K.M.
Giltnane J.M.
Estrada M.V.
Jansen V.M.
Servetto A.
Gavila J.J.
Perez-Fidalgo A.
Lluch A.
Llombart-Cussac A.
Bayar M.A.
Michiels S.
Andre F.
Arnedos M.
Guillem V.
Ruiz-Simon A.
Arteaga C.L.
Publisher(s)
American Association for Cancer Research Inc.
Abstract
In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
Start page
1431
Volume
25
Issue
4
Language
English
OCDE Knowledge area
Oncología
Scopus EID
2-s2.0-85061570035
PubMed ID
Source
Clinical Cancer Research
ISSN of the container
10780432
Sponsor(s)
National Cancer Institute - K12CA090625 - NCI
Sources of information:
Directorio de Producción Científica
Scopus